DORSA CAROLINE sold 58.1% of their position (7.50K shares) of INTELLIA THERAPEUTICS, INC. on the open market
Open‑market sale worth $616.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 4/6/2021ACC: 0001209191-21-025734
Director
Since May 2019
-7.50K
Net shares
Net seller
$616.4K
Total sold
3
Open market trades
0B · 3S
5
Total transactions
7.50K acquired · 15K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+7.50K
Price / share
$6.40
Trade value
$48K
% of position
138.6%
4/5/2021
5.41K→12.91K
Common Stock
Direct
Shares
−2.01K
Price / share
$81.49
Trade value
$164.12K
% of position
15.6%
4/5/2021
12.91K→10.90K
Common Stock
Direct
Shares
−4.69K
Price / share
$82.35
Trade value
$385.89K
% of position
43.0%
4/5/2021
10.90K→6.21K
Common Stock
Direct
Shares
−800.00
Price / share
$82.99
Trade value
$66.39K
% of position
12.9%
4/5/2021
6.21K→5.41K
Total
Net shares
+0.00
Net value
-$568.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/5/2021 | M · Option Exercise | +7.50K | $6.40 | $48K | 138.6% | 5.41K | 12.91K |
| Common Stock Direct | 4/5/2021 | S · Sale | −2.01K | $81.49 | $164.12K | 15.6% | 12.91K | 10.90K |
| Common Stock Direct | 4/5/2021 | S · Sale | −4.69K | $82.35 | $385.89K | 43.0% | 10.90K | 6.21K |
| Common Stock Direct | 4/5/2021 | S · Sale | −800.00 | $82.99 | $66.39K | 12.9% | 6.21K | 5.41K |
| Total | +0.00 | -$568.40K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
7.50K shares
Shares
−7.50K
Strike price
6.40
Held after
9.09K
Exercisable
—
4/5/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock7.50K shares | 4/5/2021 | M · Option Exercise | −7.50K | 6.40 | — | 9.09K |